1-6 of 6
Jie Ma
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

High Rates of Remission with the Initial Treatment of Oral Selinexor Plus CHOP for Newly Diagnosed Peripheral T-Cell Lymphoma (PTCL): Clinical Outcomes Analysis of a Multi-Center Phase II Study in China

Kaiyang Ding, Jie Ma, Xiaohui Zhang, Chunling Wang, Huang Hongming, Lixia Sheng, Hailing Liu, Lei Cao, Wei Wu, Jianyong Li, Lei Fan
Journal: Blood
Blood (2023) 142 (Supplement 1): 1696.
https://doi.org/10.1182/blood-2023-182553
Published: 2023
Journal Articles

Clinical Characteristics of Shwachman-Diamond Syndrome in China - Result from Childhood Bone Marrow Failure Diseases Register of China Alliance for Blood Diseases(cBMFR-CABD)

Yang Wan, Xia Qin, Shengjiang Tan, Jianping Liu, Hailong He, Xiuli Ju, Yufeng Liu, Yu Jie, Sun Yuan, Qun Hu, Xiaoyan Wu, Rong Liu, Jie Ma, Jing Chen, Alan Warren, Xiaofan Zhu, Xiangfeng Tang
Journal: Blood
Blood (2023) 142 (Supplement 1): 2543.
https://doi.org/10.1182/blood-2023-188252
Published: 2023
Journal Articles

Renal Response of Selinexor, Pomalidomide, Bortezomib and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients with Renal Impairment: A Prospective, Open-Label, Multicenter, Phase 2 Study

Huixing Zhou, Long Chang, Jing Jia, Jie Ma, Hua Xue, Hao Li, Wenrong Huang, Hebing Zhou, Jingnan Sun, Liping Su, Yanping Ma, Huang Hongming, Hongmei Jing, Zhenling Li, Guangyu Ma, Guohong Su, Jihao Zhou, Biyun Chen, LI Bao, Zhihua Zhang, Lin Yang, Haiping Yang, Yanhong Zhao, Chunyan Sun, Qingming Wang, Qimuge Saiyin, Da Gao, Xiaoxia Chu, Zhenfang Xi, Weiwei Tian, Xuliang Shen, Shi Minxia, Jin Zhang, Yi Chen, Jingbo Xu, Yao Liu, Hongling Peng, Weijun Fu, Jun Luo, Zhenyu Li, Hui-Han Wang, Xiaobo Wang, Xiuli Sun, Jinqiao Zhang, Wei WANG, Yan Yan, Yafei Wang, Xin Du, Yonghuai Feng, Yi Wang, Ying Sun, Liye Zhong, Li Gao, Wenming Chen, Jian Li, Wen Gao
Journal: Blood
Blood (2023) 142 (Supplement 1): 4754.
https://doi.org/10.1182/blood-2023-180736
Published: 2023
Journal Articles

Preliminary Results of a Phase Ⅱ Study of Zanubrutinib Combined with Immunochemotherapy in Patients with CD79A/CD79B-Mutant Diffuse Large B-Cell Lymphoma

Zhihua Yao, Zheng Yan, Shuna Yao, Haiying Wang, Junfeng Chu, Shuang Zhao, Jie Ma, Bing Wei, Jiawen Zheng, Quande Lin, Zheng Xu, Xinyang Zhao, Yanyan Liu
Journal: Blood
Blood (2022) 140 (Supplement 1): 3767–3768.
https://doi.org/10.1182/blood-2022-165944
Published: 2022
Journal Articles

Renal Response of Pomalidomide with Bortezomib and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients with Renal Impairment: A Prospective, Open-Label, Multicenter, Phase 2 Study

Yuan Jian, Long Chang, Mingxia Shi, Ying Sun, Xiaoxia Chu, Hua Xue, Wenrong Huang, Xuliang Shen, Jie Ma, Guorong Jia, Yaqing Feng, Zhenfang Xi, Yanhong Zhao, Yanping Ma, Jing Xiao, Guangyu Ma, Qingming Wang, Li Bao, Yujun Dong, Hebing Zhou, Chunyan Sun, Guohong Su, Yan Yan, Saiyin Qimuge, Liping Su, Jingnan Sun, Weiwei Tian, Xiuli Sun, Hongmei Jing, Da Gao, Wenming Chen, Jian Li, Wen Gao
Journal: Blood
Blood (2022) 140 (Supplement 1): 10167–10169.
https://doi.org/10.1182/blood-2022-159361
Published: 2022
Journal Articles

PRDM1 is involved in chemoresistance of T-cell lymphoma and down-regulated by the proteasome inhibitor

Brief Report
Wei-Li Zhao, Yan-Yan Liu, Qun-Ling Zhang, Li Wang, Christophe Leboeuf, Yi-Wen Zhang, Jie Ma, José-Francisco Garcia, Yong-Ping Song, Jun-Min Li, Zhi-Xiang Shen, Zhu Chen, Anne Janin, Sai-Juan Chen
Journal: Blood
Blood (2008) 111 (7): 3867–3871.
https://doi.org/10.1182/blood-2007-08-108654
Published: 2008